Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
2 other identifiers
observational
2
1 country
2
Brief Summary
Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with an inborn error of metabolism. Also, to create a pregnancy registry of inborn errors of metabolism. Eligibility:
- Women with an inborn error of metabolism who either:
- have been pregnant in the past,
- are currently pregnant, or
- have recently talked with their doctor about becoming pregnant. Design:
- This study will collect data only. No extra tests will be done.
- Participants will be in the study for the length of their pregnancy and for 1 year after delivery.
- Participants will answer questions about their family s health.
- The participant s doctor will send their medical records to researchers. These may include data about:
- Last health care visit before pregnancy
- Blood, urine, ultrasound, or lab results during pregnancy
- Delivery and recovery after delivery
- Researchers will ask for the test(s) used to confirm pregnancy.
- After the participant has her baby, researchers will ask for data about how the baby is doing. This may include when the baby is sitting, walking, talking, etc.
- The data will be placed into a database. The database will not include the participant s name or identifying data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2014
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2014
CompletedStudy Start
First participant enrolled
December 19, 2014
CompletedFirst Posted
Study publicly available on registry
December 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2018
CompletedMay 1, 2026
September 9, 2025
3.7 years
December 19, 2014
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal inborn errors of metabolism
Yearly
Study Arms (1)
1
Participants are women with inborn errors of metabolism who have been pregnant
Eligibility Criteria
Participants are women with inborn errors of metabolism who have been pregnant
You may qualify if:
- Patients clinically diagnosed with methylmalonic acidemia or another inborn error of metabolism are eligible to participate; mutational and enzymatic status is preferred but not required. Biochemical testing is required.
- Women with inborn errors of metabolism who have had a clinically documented prior pregnancy, currently are pregnant or planning a pregnancy.
You may not qualify if:
- Patients with phenylketonuria or hyperphenylalaninemia.
- Anyone unwilling to provide informed consent (for themselves as adults, or on behalf of their children as minors) or assent.
- We will review a clinical description from the referring physician about a potential research subject to determine that the subject is appropriate to enter into the study. We reserve the right to exclude cases that are not definitively diagnosed by metabolites and/or molecular genetics or related to our direct research interests. We expect this to be a rare minority.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (2)
Kuseyri O, Weissbach A, Bruggemann N, Klein C, Gizewska M, Karall D, Scholl-Burgi S, Romanowska H, Krzywinska-Zdeb E, Monavari AA, Knerr I, Yapici Z, Leuzzi V, Opladen T. Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders. J Inherit Metab Dis. 2018 Sep;41(5):849-863. doi: 10.1007/s10545-018-0169-0. Epub 2018 Mar 28.
PMID: 29594647BACKGROUNDRaval DB, Merideth M, Sloan JL, Braverman NE, Conway RL, Manoli I, Venditti CP. Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review. J Inherit Metab Dis. 2015 Sep;38(5):839-46. doi: 10.1007/s10545-014-9802-8. Epub 2015 Jan 8.
PMID: 25567501BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles P Venditti, M.D.
National Human Genome Research Institute (NHGRI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2014
First Posted
December 23, 2014
Study Start
December 19, 2014
Primary Completion
August 20, 2018
Study Completion
August 20, 2018
Last Updated
May 1, 2026
Record last verified: 2025-09-09